Searched for
HETERO PHARMA
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- Sun Pharma, Hetero recall drugs in US marketAs per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Optimus too could launch Covid pill Paxlovid soonThe company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator ...
- Hetero Group acquires 600 acres in Hyderabad from US fundIn 2017, it bought 20 acres of land from Puravankara Group for Rs 475 crore in the IT belt of Raidurg.
- Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...
- IT department detects Rs 550 crore in hidden income after raids on Hetero pharma group"During the search, several bank lockers have been found, out of which 16 lockers have been operated. The searches have resulted in the sei...
- Hetero begins Sputnik V production at Hyderabad facilityIn an interaction with the Russian president Vladimir Putin on Friday through a video conference, Hetero group’s Chairman Dr Bandi Parthasa...
- Gilead won't launch its Covid drug in JulyGilead has issued licences to nine generic drug companies to make and sell remdesivir. Six of the companies are Indian - Hetero, Cipla, Dr ...
- Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across IndiaThe company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to ...
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- InvaGen, Exelan acquisition will give Cipla manufacturing plant, R&D base in USCipla on Friday fulfilled a longstanding desire to expand its beachhead in the US by buying Hetero Pharma’s US business for about $550 mill...
- Hetero launches biosimilar Rituximab in IndiaHyderabad based Hetero pharma has launched biosimilar drug Rituximab under the brand name of MABALL, used in the treatment of blood cancer.
- Compulsory licensing hit India’s image: Hetero PharmaHyderabadbased Hetero Pharma said that the country has lost nearly $10 billion worth of investment by not respecting IP norms.
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Swine flu: Hetero Healthcare increases Fluvir production by 400%Hetero has dedicated manufacturing facilities at Visakhapatnam in Andhra Pradesh and Baddi in Himachal Pradesh exclusively to produce the d...
- Hyderabad's Hetero Group enters UAE with new ventureThe first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent PoolHyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...
- Pharma companies donate tamifluThe Indian arm of Swiss pharma major Hoffmann-La Roche and Hyderabad-based Hetero Drugs have together donated one lakh dosages of Tamiflu m...
- Small firms all set to pep up pharma retailOrganised pharma retail, dominated by the likes of Apollo and Subiksha, is set for more action at the regional level.
Load More
